- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03137472
TMS for Complex Regional Pain Syndrome
November 20, 2023 updated by: Sean Mackey, Stanford University
Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)
The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS).
It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline.
Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Birute Gedrimaite
- Phone Number: (650) 497-0485
- Email: birute@stanford.edu
Study Locations
-
-
California
-
Redwood City, California, United States, 94043
- Recruiting
- Stanford Pain Management Center
-
Contact:
- Birute Gedrimaite
- Phone Number: 650-497-0485
- Email: birute@stanford.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-70
- Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months
- Average pain level reported on Numerical Rating Scale meets entry criteria
- Ability to perform the experimental task and procedures.
Exclusion Criteria:
- MRI contraindication (metal implants or devices, claustrophobia)
- TMS Contraindication (eg metal implant or devices near the site of stimulation)
- History of epilepsy
- History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- Neurologic illness that would interfere with brain integrity
- Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- Currently pregnant or planning to become pregnant.
- On going legal action or disability claim.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active Treatment
Participants will receive active TMS in the target area once daily for two days
|
The Magventure TMS stimulator will be used to perform intermittent theta burst followed by high frequency Transcranial Magnetic Stimulation (TMS).
|
Sham Comparator: Sham Treatment
Participants will receive active TMS in a non-target area once daily for two days
|
The Magventure TMS stimulator will be used to perform intermittent theta burst followed by high frequency Transcranial Magnetic Stimulation (TMS).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain
Time Frame: 1 week follow-up compared to baseline
|
Decrease in CRPS-related Pain Ratings
|
1 week follow-up compared to baseline
|
Duration of Pain Relief
Time Frame: Duration from last treatment until pain returns - up to an estimate of 6 months
|
Duration of decreased CRPS-related pain ratings, measured as a length of time until pain returns for two consecutive weeks
|
Duration from last treatment until pain returns - up to an estimate of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain-related Symptomology
Time Frame: Duration from last treatment until pain returns - up to an estimate of 6 months
|
Decreases in Pain-related Symptomology (i.e., cognitive, emotional and physical)
|
Duration from last treatment until pain returns - up to an estimate of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 24, 2017
Primary Completion (Estimated)
June 29, 2024
Study Completion (Estimated)
June 29, 2024
Study Registration Dates
First Submitted
April 28, 2017
First Submitted That Met QC Criteria
April 28, 2017
First Posted (Actual)
May 2, 2017
Study Record Updates
Last Update Posted (Estimated)
November 22, 2023
Last Update Submitted That Met QC Criteria
November 20, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25894-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complex Regional Pain Syndromes
-
Danish Pain Research CenterCompletedCRPS (Complex Regional Pain Syndromes)Denmark
-
Johns Hopkins UniversityPriCara, Unit of Ortho-McNeil, Inc.CompletedPeripheral Neuropathy | Complex Regional Pain Syndromes (CRPS)
-
Danish Pain Research CenterCompleted
-
Hospital for Special Surgery, New YorkRecruitingCRPS (Complex Regional Pain Syndromes)United States
-
The Cleveland ClinicMurdoch UniversityTerminatedComplex Regional Pain Syndrome (CRPS)United States
-
Stanford UniversityCompletedComplex Regional Pain Syndrome (CRPS)United States
-
Stanford UniversityCompleted
-
Vibhor KrishnaMedtronicCompletedComplex Regional Pain Syndrome (CRPS) | Neuropathic Leg PainUnited States
-
Grünenthal GmbHTerminatedComplex Regional Pain Syndrome (CRPS)United States, Australia, France, Germany, Korea, Republic of, New Zealand, Spain
-
University of Sao PauloUniversity of Sao Paulo General HospitalUnknownComplex Regional Pain Syndrome I of Upper LimbBrazil
Clinical Trials on Transcranial Magnetic Stimulation (TMS)
-
Emory UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Centre Hospitalier St AnneNot yet recruitingTreatment Resistant Schizophrenia
-
Northwestern UniversityCompletedHealthyUnited States
-
University of FloridaActive, not recruiting
-
Huashan HospitalUnknown
-
University of California, San DiegoNational Institutes of Health (NIH)RecruitingMajor Depressive DisorderUnited States, Australia
-
University of ManitobaRecruiting
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Beth Israel Deaconess Medical CenterTerminated
-
Northwestern UniversityRecruiting